Medipixel AI Engine enables 3rd party’s surgery robots to perform complex actions without human intervention. Initially starting from percutaneous coronary intervention procedure, Medipixel is expanding its domain to other domains such as peripheral vascular intervention procedure, neuro-interventional procedure, and even laparoscopy surgery procedure.
Medipixel is a MedTech startup that aims to contribute to the improvement of the quality of human life by innovating the way we diagnose diseases and controlling surgical robots with the power of AI. Consisting of a group of AI experts in computer vision, deep learning, and reinforcement learning, Medipixel conducts research and product development for cardiovascular disease diagnosis and coronary intervention robots together with the best healthcare professionals in Korea such as Seoul Asan Medical Center. In November 2018, MediPixel won the championship in the QuickFire Challenge hosted by Johnson & Johnson.
Total Funding: $1,740,000
Funding Stage: Seed
Business Stage: Scaling Up
Market: B2B
Company Size: 26 to 50
Founded: 2017
BDM (Business Development Manager)
Seoul, Seoul
Regulatory Affairs Specialist
Seoul, Seoul
Research Director
Seoul, Seoul
Research Engineer on Medical Imaging
Seoul, Seoul
Research Engineer on Reinforcement Learning
Seoul, Seoul
